Related Experiment Videos
[Gamma knife radiosurgery in neurosurgery]
J Siegfried1, D Haller, F Heinzel
1Gamma-Knife-Zentrum, Klinik Im Park.
Schweizerische Medizinische Wochenschrift
|April 2, 1998
Summary
The Gamma Knife, a radiosurgery device, effectively treats deep-seated brain tumors and arteriovenous malformations. This advanced technique shows promising results with zero morbidity and mortality in early patient follow-ups.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Physics
Context:
- Stereotactic radiosurgery is a minimally invasive treatment for intracranial pathologies.
- The Gamma Knife utilizes focused radiation beams for precise tumor ablation.
- Established over 40 years ago, it has become a leading radiosurgery method globally.
Purpose:
- To evaluate the efficacy and safety of Gamma Knife radiosurgery for brain tumors and arteriovenous malformations.
- To assess treatment outcomes including tumor volume changes and obliteration rates.
- To report initial findings on morbidity and mortality in a patient cohort.
Summary:
- The Gamma Knife treats brain tumors and arteriovenous malformations (AVMs) up to 3 cm in diameter in a single session.
- Benign tumors showed volume stabilization followed by reduction; pituitary adenomas and brain metastases responded well.
- AVMs required 2-3 years for complete nidus obliteration, with zero reported morbidity or mortality.
Impact:
- Gamma Knife radiosurgery offers a valuable alternative or complement to traditional microsurgery for various brain conditions.
- Demonstrates a high safety profile with no observed morbidity or mortality in the treated patient series.
- Contributes to the growing body of evidence supporting radiosurgery's role in neuro-oncology and vascular neurosurgery.